Pulchinenoside B4 ameliorates oral ulcers in rats by modulating gut microbiota and metabolites
Open Access
- 9 April 2024
- journal article
- research article
- Published by Springer Nature in Applied Microbiology and Biotechnology
- Vol. 108 (1) , 1-16
Abstract
Pulchinenoside B4, a natural saponin monomer from the Pulsatilla plant, plays an important role as an immunomodulator in the treatment of acute inflammation. Oral ulcer (OU) is a common ulcerative injury disease that occurs in the oral mucosa, including mucosal ulceration and abnormalities of lips and tongue. A close correlation exists between gut microbiota and circulating metabolites in patients with OU. However, the correlation between gut microbiota and serum metabolomics is not clear. Therefore, this study aimed to explore the changes in gut microbiota and metabolites in OU. The 16S ribosomal RNA (16S rRNA) gene sequencing was used to detect the changes in the composition of gut microbiota in OU rat model. Moreover, the endogenous small metabolites were explored by collecting the non-targeted serum metabolomics data. A total of 34 OU-related biomarkers were identified, mainly related to fatty acid metabolism and inflammatory pathways. The administration of B4 effectively reduced the occurrence of OU and restored the levels of multiple endogenous biomarkers and key gut microbial species to the normal level. This study demonstrated that the gut microbiota and metabolites were altered in the OU rat model, which were significantly restored to the normal level by B4, thereby showing good application prospects in the treatment of OU. Key points: • The first investigating the correlation between OU and gut microbiota. • A close correlation between metabolites and gut microbiota in OU disease was successfully identified. • Pulchinenoside B4 ameliorates oral ulcers in rats by modulating gut microbiota and metabolites.Keywords
Funding Information
- The National Key R&D Program of China (2019YFC1712302, 2019YFC1712304)
- Jiangxi Science and Technology Innovation Platform Project (20194AFD45001)
- Special projects of local science and technology development guided by the central government (20192ZDD02002)
- the University-Enterprise cooperation transverse project (No. 20220046)
- Jiangxi University of Chinese Medicine Science and Technology Innovation Team Development Program (CXTD22001)
This publication has 34 references indexed in Scilit:
- Altered gut microbiome in FUT2 loss-of-function mutants in support of personalized medicine for inflammatory bowel diseasesJournal of Genetics and Genomics, 2021
- Hepatoprotective effect of anemoside B4 against sepsis-induced acute liver injury through modulating the mTOR/p70S6K-mediated autophagyChemico-Biological Interactions, 2021
- Mouth ulcers and diseases of the oral cavityMedicine, 2021
- Integrated gut microbiota and fecal metabolomics reveal the renoprotective effect of Rehmanniae Radix Preparata and Corni Fructus on adenine-induced CKD ratsJournal of Chromatography B, 2021
- 3D printed tacrolimus suppositories for the treatment of ulcerative colitisAsian Journal of Pharmaceutical Sciences, 2021
- Anemoside B4 prevents acute ulcerative colitis through inhibiting of TLR4/NF-κB/MAPK signaling pathwayInternational Immunopharmacology, 2020
- In vitro and human pharmacoscintigraphic evaluation of an oral 5-ASA delivery system for colonic releaseInternational Journal of Pharmaceutics, 2019
- A consensus orthogonal partial least squares discriminant analysis (OPLS-DA) strategy for multiblock Omics data fusionAnalytica Chimica Acta, 2013
- Links between the species abundance distribution and the shape of the corresponding rank abundance curveEcological Indicators, 2012
- Intestinal flora in health and diseaseGastroenterology, 1984